Cytotoxic T Lymphocytes
Sponsors
Medical College of Wisconsin, Thomas Jefferson University
Conditions
AdenovirusCovid19Cytomegalovirus InfectionsEpstein-Barr Virus Infections
Phase 1
Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV
CompletedNCT01535885
Start: 2012-02-29End: 2019-10-31Updated: 2021-10-25
Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection
CompletedNCT04765449
Start: 2021-09-15End: 2023-01-19Updated: 2025-04-29